Here is the link to the company's investor relations with disclaimer. http://vitrobiopharma.com/2014/02/11/vitro-biopharma-revenues-increase-early-2014-plans-trials-endogenous-stem-cell-activation-therapeutic-benefit/ Think you might be wrong on this one satelliteguy...